Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:18 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 1,536,000 8.730% | 1,536,000 (New Position) | View |
| 2024-11-14 3:33 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 934,788 5.300% | 934,788 (New Position) | View |
| 2024-11-08 09:33 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | Invesco Ltd. IVZ | 1,051,355 6.000% | 1,051,355 (New Position) | View |
| 2024-02-14 2:30 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 17,100,000 9.810% | 144,000 (+0.85%) | View |
| 2024-02-13 5:13 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 8,953,217 5.130% | -3,130,579 (-25.91%) | View |
| 2024-02-09 12:17 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | MORGAN STANLEY MS | 14,490,600 8.300% | 14,490,600 (New Position) | View |
| 2024-02-05 5:34 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | GOLDMAN SACHS GROUP INC GS | 255,676 0.100% | -9,114,387 (-97.27%) | View |
| 2024-02-02 09:56 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 9,442,579 5.400% | 219,564 (+2.38%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 15,198,077 8.700% | 517,013 (+3.52%) | View |
| 2023-06-12 08:21 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 200,821 0.115% | -8,691,186 (-97.74%) | View |
| 2023-02-22 4:03 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 9,223,015 5.300% | 9,223,015 (New Position) | View |
| 2023-02-14 2:40 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | GOLDMAN SACHS GROUP INC GS | 9,370,063 5.400% | 9,370,063 (New Position) | View |
| 2023-02-14 1:21 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 16,956,000 9.810% | 16,956,000 (New Position) | View |
| 2023-02-09 12:31 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 8,892,007 5.144% | -6,594,580 (-42.58%) | View |
| 2023-02-09 11:30 am Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | VANGUARD GROUP INC | 12,083,796 6.990% | 3,055,682 (+33.85%) | View |
| 2023-02-06 1:20 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 3,374,914 1.950% | -503,152 (-12.97%) | View |
| 2023-02-03 4:27 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | BlackRock Inc. BLK | 14,681,064 8.500% | -1,870,920 (-11.30%) | View |
| 2022-10-11 2:06 pm Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | STATE STREET CORP STT | 3,878,066 2.240% | -20,067,502 (-83.80%) | View |
| 2022-10-11 09:03 am Sale | 13G | RIGEL PHARMACEUTICALS INC RIGL | FMR LLC | 15,486,587 8.960% | -9,085,006 (-36.97%) | View |
| 2022-09-22 4:02 pm Purchase | 13G | RIGEL PHARMACEUTICALS INC RIGL | MILLENNIUM MANAGEMENT LLC | 7,591,121 4.400% | 7,591,121 (New Position) | View |